EICHORCondition: Prostate Cancer · Sponsor: Andreas Josefsson
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This project's objective is to initiate a prospective non-interventional clinical study to perform full molecular characterization and subtyping of the primary tumor prostate cancer patients. It will identify, compare, and select biomarkers for treatment response in high-risk/metastatic prostate cancer.
This description comes directly from the study's public registry record.
Andreas Josefsson, MD, PhD · +46 907850000 · andreas.josefsson@umu.se
Karin Welen, PhD · karin.welen@urology.gu.se
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Men investigated for suspected prostate cancer * Signed consent form Exclusion Criteria: * Difficulties understanding information about the study due to linguistic, cognitive or other reason
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Urology, Umeå University Hospital, Region Västerbotten | Umeå, Sweden | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06687421